Inozyme Pharma (INZY) Earnings Date & Reports

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INZY is expected to report earnings to fall 2.78% to -39 cents per share on May 13

Inozyme Pharma INZY Stock Earnings Reports

Q1'25

Est.

$-0.40

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.05

Q2'24

Missed

by $0.04

Q1'24

Missed

by $0.03

The last earnings report on March 10 showed earnings per share of -40 cents, missing the estimate of -40 cents. With 527.51K shares outstanding, the current market capitalization sits at 66.17M.

View a ticker or compare two or three

Compare

INZY